Stoneridge Investment Partners LLC Increases Stock Holdings in Enhabit, Inc. (NYSE:EHAB)

Stoneridge Investment Partners LLC lifted its stake in shares of Enhabit, Inc. (NYSE:EHABFree Report) by 22.6% in the 4th quarter, Holdings Channel reports. The institutional investor owned 12,533 shares of the company’s stock after acquiring an additional 2,308 shares during the quarter. Stoneridge Investment Partners LLC’s holdings in Enhabit were worth $98,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. Jane Street Group LLC lifted its stake in Enhabit by 514.3% in the third quarter. Jane Street Group LLC now owns 901,084 shares of the company’s stock valued at $7,119,000 after buying an additional 754,395 shares during the last quarter. Systematic Financial Management LP raised its position in Enhabit by 12.2% in the 3rd quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock valued at $14,522,000 after purchasing an additional 199,235 shares during the last quarter. Bardin Hill Management Partners LP boosted its stake in Enhabit by 927.4% during the 3rd quarter. Bardin Hill Management Partners LP now owns 174,304 shares of the company’s stock worth $1,377,000 after purchasing an additional 157,338 shares during the period. West Tower Group LLC grew its position in Enhabit by 108.8% during the 3rd quarter. West Tower Group LLC now owns 285,142 shares of the company’s stock worth $2,253,000 after purchasing an additional 148,566 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its stake in Enhabit by 37.8% in the third quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company’s stock valued at $2,411,000 after purchasing an additional 83,707 shares during the period.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on EHAB shares. Leerink Partners reiterated a “market perform” rating and set a $8.00 target price (down previously from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th. Jefferies Financial Group raised Enhabit from a “hold” rating to a “buy” rating and increased their price objective for the stock from $8.25 to $9.50 in a research report on Monday, December 9th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, Enhabit currently has a consensus rating of “Hold” and a consensus target price of $8.75.

Get Our Latest Report on EHAB

Enhabit Trading Up 0.8 %

Shares of Enhabit stock opened at $8.31 on Friday. The firm has a market cap of $417.86 million, a price-to-earnings ratio of -3.58 and a beta of 1.83. Enhabit, Inc. has a 52-week low of $6.85 and a 52-week high of $11.74. The company’s 50-day simple moving average is $8.06 and its 200-day simple moving average is $8.03. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85.

Enhabit (NYSE:EHABGet Free Report) last released its earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The business had revenue of $253.60 million for the quarter, compared to analyst estimates of $261.69 million. During the same quarter in the previous year, the firm posted $0.03 EPS. As a group, equities research analysts anticipate that Enhabit, Inc. will post 0.22 earnings per share for the current year.

Insider Activity

In related news, Director Stuart M. Mcguigan purchased 15,000 shares of the company’s stock in a transaction on Tuesday, December 10th. The stock was bought at an average price of $8.81 per share, with a total value of $132,150.00. Following the completion of the transaction, the director now owns 46,810 shares of the company’s stock, valued at approximately $412,396.10. This represents a 47.15 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jeffrey Bolton purchased 4,000 shares of the firm’s stock in a transaction on Thursday, December 12th. The shares were purchased at an average cost of $8.69 per share, for a total transaction of $34,760.00. Following the completion of the purchase, the director now directly owns 98,144 shares in the company, valued at $852,871.36. The trade was a 4.25 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 1.90% of the company’s stock.

About Enhabit

(Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Read More

Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHABFree Report).

Institutional Ownership by Quarter for Enhabit (NYSE:EHAB)

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.